Hiv research news

Here are some recent HIV research news and updates:

New HIV Vaccine Candidate Shows Promise

A new HIV vaccine candidate, known as mRNA-1647, has shown promising results in a phase 1 clinical trial. The vaccine uses a piece of genetic material called messenger RNA (mRNA) to stimulate the immune system to produce antibodies that can recognize and attack HIV. The trial found that the vaccine was safe and induced strong immune responses in participants. (Source: National Institute of Allergy and Infectious Diseases)

HIV Treatment as Prevention (TasP) Shows Long-Term Benefits

A study published in The Lancet found that treating HIV-positive individuals with antiretroviral therapy (ART) as soon as they are diagnosed (TasP) can reduce the risk of HIV transmission to sexual partners by 93% over a period of 12 months. The study also found that TasP can reduce the risk of HIV transmission to infants born to HIV-positive mothers by 74%. (Source: The Lancet)

New HIV Diagnostic Test Uses Artificial Intelligence

Researchers have developed a new HIV diagnostic test that uses artificial intelligence (AI) to analyze blood samples and detect the virus. The test, known as the "AI-powered HIV diagnostic test," is faster and more accurate than traditional diagnostic tests and can detect HIV in as little as 20 minutes. (Source: Science Daily)

HIV Cure Research Makes Progress

Researchers have made progress in their quest to develop a cure for HIV. A study published in the journal Nature Medicine found that a combination of antiretroviral therapy (ART) and a gene editing tool called CRISPR-Cas9 can eliminate HIV from the cells of infected individuals. The study used a mouse model of HIV infection and found that the combination therapy was able to eliminate the virus from the animals' cells. (Source: Nature Medicine)

HIV Prevention Pill Shows Promise

A study published in The Lancet found that a daily pill containing the antiretroviral medication tenofovir disoproxil fumarate (TDF) can reduce the risk of HIV transmission in individuals who are at high risk of infection. The study found that the pill reduced the risk of HIV transmission by 44% over a period of 24 weeks. (Source: The Lancet)

HIV/AIDS Deaths Decline, But Progress Remains Uneven

According to a report by the Joint United Nations Programme on HIV/AIDS (UNAIDS), the number of deaths from HIV/AIDS has declined by 47% since 2000. However, progress remains uneven, with some regions and populations still experiencing high rates of HIV transmission and mortality. The report calls for continued efforts to address the epidemic and achieve the UNAIDS 90-90-90 targets, which aim to diagnose 90% of all people living with HIV, provide antiretroviral therapy (ART) to 90% of those diagnosed, and achieve viral suppression for 90% of those on ART. (Source: UNAIDS)